BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Grozinsky-Glasberg S, Thomas D, Strosberg JR, Pape UF, Felder S, Tsolakis AV, Alexandraki KI, Fraenkel M, Saiegh L, Reissman P, Kaltsas G, Gross DJ. Metastatic type 1 gastric carcinoid: A real threat or just a myth? World J Gastroenterol 2013; 19(46): 8687-8695 [PMID: 24379587 DOI: 10.3748/wjg.v19.i46.8687]
URL: https://www.wjgnet.com/1007-9327/full/v19/i46/8687.htm
Number Citing Articles
1
Duan Chen, Susan J. Hagen, Malcolm Boyce, Chun‐Mei Zhao. Neuroendocrine mechanism of gastric acid secretion: Historical perspectives and recent developments in physiology and pharmacologyJournal of Neuroendocrinology 2023; 35(11) doi: 10.1111/jne.13305
2
Evita Henderson-Jackson, Ujalla Sheikh, Jalil Muhammad, Domenico Coppola, Aejaz Nasir. Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic Advances2016; : 217 doi: 10.1007/978-1-4939-3426-3_12
3
A. Malczewska, A. Procner, A. Walter, K. Kusnierz, W. Zajecki, H. Aslanian, B. Kos-Kudla. The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual diseaseBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01348-2
4
Marina Tsoli, Eleftherios Chatzellis, Anna Koumarianou, Dionysia Kolomodi, Gregory Kaltsas. Current best practice in the management of neuroendocrine tumorsTherapeutic Advances in Endocrinology and Metabolism 2019; 10: 204201881880469 doi: 10.1177/2042018818804698
5
Joana  Carvão, Mário Dinis-Ribeiro, Pedro Pimentel-Nunes, Diogo Libânio. Neuroendocrine Tumors of the Gastrointestinal Tract: A Focused Review and Practical Approach for GastroenterologistsGE - Portuguese Journal of Gastroenterology 2021; 28(5): 336 doi: 10.1159/000512089
6
Liv Sagatun, Patricia Mjønes, Constantin S. Jianu, Malcolm Boyce, Hege L. Waldum, Reidar Fossmark. The gastrin receptor antagonist netazepide (YF476) in patients with type 1 gastric enterochromaffin-like cell neuroendocrine tumours: review of long-term treatmentEuropean Journal of Gastroenterology & Hepatology 2016; 28(11): 1345 doi: 10.1097/MEG.0000000000000713
7
Hüseyin Köseoğlu, Tolga Duzenli, Mesut Sezikli. Gastric neuroendocrine neoplasms: A reviewWorld Journal of Clinical Cases 2021; 9(27): 7973-7985 doi: 10.12998/wjcc.v9.i27.7973
8
Oriol Calvete, Jose Reyes, Sheila Zuñiga, Beatriz Paumard-Hernández, Victoria Fernández, Luís Bujanda, María S. Rodriguez-Pinilla, Jose Palacios, Damian Heine-Suñer, Siddharth Banka, William G. Newman, Marta Cañamero, D. Mark Pritchard, Javier Benítez. Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastric neuroendocrine tumourHuman Molecular Genetics 2015; 24(10): 2914 doi: 10.1093/hmg/ddv054
9
Zhi-hao Yang, Yi-jing Han, Ming Cheng, Rui Wang, Jing Li, Hui-ping Zhao, Jian-bo Gao. Prognostic value of computed tomography radiomics features in patients with gastric neuroendocrine neoplasmFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1143291
10
Michael Rassner, Harald Lahner, Nikolas von Bubnoff, Frank Lammert. Geriatrische Onkologie2018; : 381 doi: 10.1007/978-3-662-48727-3_30
11
Tanya Odisho, Dongping Shi, Ahmad Aburashed. Successful endoscopic resection of an unusually enlarged and pedunculated type I gastric carcinoid tumourBMJ Case Reports 2021; 14(8): e244292 doi: 10.1136/bcr-2021-244292
12
Sandip Pal, Digvijay Hodgar. Gastrointestinal Subepithelial Lesions: A ReviewJournal of Digestive Endoscopy 2023; 14(02): 099 doi: 10.1055/s-0043-1770923
13
Sara Massironi, Alessandra Zilli, Dario Conte. Somatostatin analogs for gastric carcinoids: For many, but not allWorld Journal of Gastroenterology 2015; 21(22): 6785-6793 doi: 10.3748/wjg.v21.i22.6785
14
Davide Ravizza, Giancarla Fiori. Neuroendocrine Neoplasia Management2021; : 179 doi: 10.1007/978-3-030-72830-4_13
15
Gregory Kaltsas, Simona Grozinsky‐Glasberg, Krystallenia I. Alexandraki, Dimitrios Thomas, Apostolos V. Tsolakis, David Gross, Ashley B. Grossman. Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasmsClinical Endocrinology 2014; 81(2): 157 doi: 10.1111/cen.12476
16
Ken Namikawa, Tomoari Kamada, Junko Fujisaki, Yuichi Sato, Takahisa Murao, Tsutomu Chiba, Yasuharu Kaizaki, Kenji Ishido, Yutaro Ihara, Koichi Kurahara, Tomoaki Suga, Haruhisa Suzuki, Masanori Ito, Katsuya Hirakawa, Yasuhiko Maruyama, Takuji Gotoda, Osamu Hosokawa, Tomohiro Koike, Katsuhiro Mabe, Takashi Yao, Kazuo Inui, Hiroyasu Iishi, Haruhiko Ogata, Takahisa Furuta, Ken Haruma. Clinical characteristics and long‐term prognosis of type 1 gastric neuroendocrine tumors in a large Japanese national cohortDigestive Endoscopy 2023; 35(6): 757 doi: 10.1111/den.14529
17
Yoshihito SHINOHARA, Takahiro TSUCHIKAWA, Yuma EBIHARA, Toshiaki SHICHINOHE, Satoshi HIRANO. Clinical Experience with Treatments of Gastric Neuroendocrine NeoplasmsNihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2022; 83(2): 263 doi: 10.3919/jjsa.83.263
18
Bernardo Marques, Raquel G Martins, Guilherme Tralhão, Joana Couto, Sandra Saraiva, Henrique Ferrão, João Ribeiro, Jacinta Santos, Teresa Martins, Ana Teresa Cadime, Fernando Rodrigues. Gastric neuroendocrine neoplasm with late liver metastasisEndocrinology, Diabetes & Metabolism Case Reports 2018; 2018 doi: 10.1530/EDM-18-0048
19
Andrea Grin, Catherine J. Streutker. Neuroendocrine Tumors of the Luminal Gastrointestinal TractArchives of Pathology & Laboratory Medicine 2015; 139(6): 750 doi: 10.5858/arpa.2014-0130-RA
20
Noble Varghese Mathews, Sudipta Dhar Chowdhury, Anoop John. Endoscopy in the Diagnosis and Management of Gastrointestinal Neuroendocrine TumorsGastroenterology, Hepatology and Endoscopy Practice 2024; 4(1): 1 doi: 10.4103/ghep.ghep_21_23
21
Chen-Shuan Chung, Cho-Lun Tsai, Yin-Yi Chu, Kuan-Chih Chen, Jung-Chun Lin, Bao-Chung Chen, Wei-Chih Sun, Hsu-Heng Yen, Chiung-Yu Chen, I-Chen Wu, Chao-Hung Kuo, Hisang-Yao Shih, Ming-Jong Bair, Jack P. Wang, Wen-Hao Hu, Chang-Shyue Yang, Ming-Lun Han, Tsu-Yao Cheng, Chao-Ming Tseng, Ming-Chang Tsai, Ming-Luen Hu, Hsiu-Po Wang. Clinical features and outcomes of gastric neuroendocrine tumors after endoscopic diagnosis and treatmentMedicine 2018; 97(38): e12101 doi: 10.1097/MD.0000000000012101
22
Natalie Patel, Andrea Barbieri, Joanna Gibson. Neuroendocrine Tumors of the Gastrointestinal Tract and PancreasSurgical Pathology Clinics 2019; 12(4): 1021 doi: 10.1016/j.path.2019.08.007
23
Valentina Andreasi, Stefano Partelli, Francesca Muffatti, Marco F. Manzoni, Gabriele Capurso, Massimo Falconi. Update on gastroenteropancreatic neuroendocrine tumorsDigestive and Liver Disease 2021; 53(2): 171 doi: 10.1016/j.dld.2020.08.031
24
Lauren M. Postlewait, Gillian G. Baptiste, Cecilia G. Ethun, Nina Le, Kenneth Cardona, Maria C. Russell, Field F. Willingham, David A. Kooby, Charles A. Staley, Shishir K. Maithel. A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?Journal of Surgical Oncology 2016; 114(5): 576 doi: 10.1002/jso.24369
25
Octreotide/peginterferon-α-2aReactions Weekly 2021; 1850(1): 223 doi: 10.1007/s40278-021-94028-y
26
Mohammad Sheikh-Ahmad, Leonard Saiegh, Anan Shalata, Jacob Bejar, Hila Kreizman-Shefer, Majd F. Sirhan, Ibrahim Matter, Forat Swaid, Monica Laniado, Nama Mubariki, Tova Rainis, Ilana Rosenblatt, Ekaterina Yovanovich, Abed Agbarya. Factors Predicting Type I Gastric Neuroendocrine Neoplasia Recurrence: A Single-Center StudyBiomedicines 2023; 11(3): 828 doi: 10.3390/biomedicines11030828
27
Katie A. Lloyd, Bryony N. Parsons, Michael D. Burkitt, Andrew R. Moore, Stamatia Papoutsopoulou, Malcolm Boyce, Carrie A. Duckworth, Klaire Exarchou, Nathan Howes, Lucille Rainbow, Yongxiang Fang, Claus Oxvig, Steven Dodd, Andrea Varro, Neil Hall, D. Mark Pritchard. Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine TumorsCellular and Molecular Gastroenterology and Hepatology 2020; 10(1): 113 doi: 10.1016/j.jcmgh.2020.01.010
28
R. Basuroy, R. Srirajaskanthan, A. Prachalias, A. Quaglia, J. K. Ramage. Review article: the investigation and management of gastric neuroendocrine tumoursAlimentary Pharmacology & Therapeutics 2014; 39(10): 1071 doi: 10.1111/apt.12698
29
Ivan Borbath, Ulrich‐Frank Pape, Pierre H. Deprez, Detlef Klaus Bartsch, Martyn Caplin, Massimo Falconi, Rocio Garcia‐Carbonero, Simona Grozinsky‐Glasberg, Robert T. Jensen, Rudolf Arnold, Philippe Ruszniewski, C. Toumpanakis, Juan W. Valle, Dermot O´Toole. ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumorsJournal of Neuroendocrinology 2022; 34(3) doi: 10.1111/jne.13105
30
Brent K. Larson, Deepti Dhall. Practical Gastrointestinal Pathology2021; : 409 doi: 10.1007/978-3-030-51268-2_17
31
Jin Hee Noh, Do Hoon Kim, Hwan Yoon, Li-Chang Hsing, Hee Kyong Na, Ji Yong Ahn, Jeong Hoon Lee, Kee Wook Jung, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung. Clinical Outcomes of Endoscopic Treatment for Type 1 Gastric Neuroendocrine TumorJournal of Gastrointestinal Surgery 2021; 25(10): 2495 doi: 10.1007/s11605-021-04997-0
32
Malcolm Boyce, Andrew R. Moore, Liv Sagatun, Bryony N. Parsons, Andrea Varro, Fiona Campbell, Reidar Fossmark, Helge L. Waldum, D. Mark Pritchard. Netazepide, a gastrin/cholecystokinin‐2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritisBritish Journal of Clinical Pharmacology 2017; 83(3): 466 doi: 10.1111/bcp.13146
33
Cemal Yazici, Brian R Boulay. Evolving role of the endoscopist in management of gastrointestinal neuroendocrine tumorsWorld Journal of Gastroenterology 2017; 23(27): 4847-4855 doi: 10.3748/wjg.v23.i27.4847
34
Xinrui Guo, Xiaohan Zhao, Gang Huang, Yanbo Yu. Advances in Endoscopic Diagnosis and Treatment of Gastric Neuroendocrine NeoplasmsDigestive Diseases and Sciences 2024; 69(1): 27 doi: 10.1007/s10620-023-08180-0
35
Johannes Hofland, Gregory Kaltsas, Wouter W de Herder. Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine NeoplasmsEndocrine Reviews 2020; 41(2): 371 doi: 10.1210/endrev/bnz004
36
S. Maasberg, C. Jürgensen, F. Scheerer, R. Pschowski, S. Felder, N. Begum, B. Wiedenmann, A. Pascher, U.-F. Pape. Endoskopische Therapie gastroduodenaler neuroendokriner NeoplasienDer Chirurg 2016; 87(4): 271 doi: 10.1007/s00104-016-0157-6
37
Francesco Panzuto, Sara Massironi, Stefano Partelli, Davide Campana, Maria Rinzivillo, Pietro Invernizzi, Valentina Andreasi, Giuseppe Lamberti, Massimo Falconi. Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative managementSurgical Oncology 2020; 35: 141 doi: 10.1016/j.suronc.2020.08.015
38
Apostolos V. Tsolakis. Encyclopedia of Endocrine Diseases2019; : 565 doi: 10.1016/B978-0-12-801238-3.66115-9
39
Yuichi Sato. Clinical features and management of type I gastric carcinoidsClinical Journal of Gastroenterology 2014; 7(5): 381 doi: 10.1007/s12328-014-0528-9
40
Pierre H. Deprez, Leon M.G. Moons, Dermot OʼToole, Rodica Gincul, Andrada Seicean, Pedro Pimentel-Nunes, Gloria Fernández-Esparrach, Marcin Polkowski, Michael Vieth, Ivan Borbath, Tom G. Moreels, Els Nieveen van Dijkum, Jean-Yves Blay, Jeanin E. van Hooft. Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) GuidelineEndoscopy 2022; 54(04): 412 doi: 10.1055/a-1751-5742
41
Sara Massironi, Alessandra Zilli, Ilaria Fanetti, Clorinda Ciafardini, Dario Conte, Maddalena Peracchi. Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritisDigestive and Liver Disease 2015; 47(11): 978 doi: 10.1016/j.dld.2015.07.155
42
Alessandro Vanoli, Stefano La Rosa, Emanuela Miceli, Catherine Klersy, Roberta Maragliano, Francesca Capuano, Andrea Persichella, Michele Martino, Frediano Inzani, Ombretta Luinetti, Antonio Di Sabatino, Fausto Sessa, Marco Paulli, Gino Roberto Corazza, Guido Rindi, Cesare Bordi, Carlo Capella, Enrico Solcia. Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-UpNeuroendocrinology 2018; 107(2): 114 doi: 10.1159/000489902
43
Hussein Nassereddine, Matthieu Chicaud, Khedidja Rebah, Nathalie Théou-Anton, Anne Sautet, Jacques Dermer, Anne Couvelard. Pathogenic ATM Variant-Harbouring Well-Differentiated Aggressive Type 1 Gastric Neuroendocrine Tumour with High-grade Features (G3 NET): a New Addition to the Clinical and Pathological Spectrum of Gastric Neuroendocrine NeoplasmsEndocrine Pathology 2021; 32(4): 517 doi: 10.1007/s12022-021-09681-2
44
Günter Klöppel, Stefano La Rosa. Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasmsVirchows Archiv 2018; 472(3): 341 doi: 10.1007/s00428-017-2258-0
45
G. Delle Fave, D. O''Toole, A. Sundin, B. Taal, P. Ferolla, J.K. Ramage, D. Ferone, T. Ito, W. Weber, Z. Zheng-Pei, W.W. De Herder, A. Pascher, P. Ruszniewski. ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine NeoplasmsNeuroendocrinology 2016; 103(2): 119 doi: 10.1159/000443168
46
Takaaki Arigami, Yoshikazu Uenosono, Shigehiro Yanagita, Keishi Okubo, Takashi Kijima, Daisuke Matsushita, Masahiko Amatatsu, Takahiko Hagihara, Naoto Haraguchi, Yuko Mataki, Katsuhiko Ehi, Sumiya Ishigami, Shoji Natsugoe. Sentinel node navigation surgery for gastroduodenal neuroendocrine tumorsMedicine 2016; 95(26): e4063 doi: 10.1097/MD.0000000000004063
47
Gurleen Pasricha, Parikshit Padhi, Nour Daboul, Dulabh K. Monga. Management of Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs): A ReviewClinical Therapeutics 2017; 39(11): 2146 doi: 10.1016/j.clinthera.2017.10.010
48
Apostolos V Tsolakis, Athanasia Ragkousi, Miroslav Vujasinovic, Gregory Kaltsas, Kosmas Daskalakis. Gastric neuroendocrine neoplasms type 1: A systematic review and meta-analysisWorld Journal of Gastroenterology 2019; 25(35): 5376-5387 doi: 10.3748/wjg.v25.i35.5376
49
Klaire Exarchou, Haiyi Hu, Nathan A. Stephens, Andrew R. Moore, Mark Kelly, Angela Lamarca, Wasat Mansoor, Richard Hubner, Mairéad G. McNamara, Howard Smart, Nathan R. Howes, Juan W. Valle, D. Mark Pritchard. Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameterEndocrine 2022; 78(1): 186 doi: 10.1007/s12020-022-03143-3
50
Francesco Panzuto, Davide Campana, Sara Massironi, Antongiulio Faggiano, Maria Rinzivillo, Giuseppe Lamberti, Valentina Sciola, Edith Lahner, Lisa Manuzzi, Annamaria Colao, Bruno Annibale. Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: A multicentre retrospective studyDigestive and Liver Disease 2019; 51(10): 1456 doi: 10.1016/j.dld.2019.04.016
51
Roberta Elisa Rossi, Pietro Invernizzi, Vincenzo Mazzaferro, Sara Massironi. Response and relapse rates after treatment with long‐acting somatostatin analogs in multifocal or recurrent type‐1 gastric carcinoids: A systematic review and meta‐analysisUnited European Gastroenterology Journal 2020; 8(2): 140 doi: 10.1177/2050640619890465
52
Liv Sagatun, Reidar Fossmark, Constantin S. Jianu, Gunnar Qvigstad, Ivar S. Nordrum, Patricia Mjønes, Helge L. Waldum. Follow-up of patients with ECL cell-derived tumoursScandinavian Journal of Gastroenterology 2016; 51(11): 1398 doi: 10.3109/00365521.2016.1169588
53
Gianluca Esposito, Emanuele Dilaghi, Maria Cazzato, Emanuela Pilozzi, Laura Conti, Marilia Carabotti, Emilio Di Giulio, Bruno Annibale, Edith Lahner. Endoscopic surveillance at 3 years after diagnosis, according to European guidelines, seems safe in patients with atrophic gastritis in a low-risk regionDigestive and Liver Disease 2021; 53(4): 467 doi: 10.1016/j.dld.2020.10.038
54
David A. Mahvi, Thomas E. Clancy. Neuroendocrine Tumors2021; : 107 doi: 10.1007/978-3-030-62241-1_7
55
Dou Dou, Yan-Fen Shi, Qing Liu, Jie Luo, Ji-Xi Liu, Meng Liu, Ying-Ying Liu, Yuan-Liang Li, Xu-Dong Qiu, Huang-Ying Tan. Hsa-miR-202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target <i>DUSP1</i>World Journal of Gastroenterology 2018; 24(5): 573-582 doi: 10.3748/wjg.v24.i5.573
56
Maria Rinzivillo, Francesco Panzuto, Gianluca Esposito, Edith Lahner, Alberto Signore, Bruno Annibale. Usefulness of 68-Gallium PET in Type I Gastric Neuroendocrine Neoplasia: A Case SeriesJournal of Clinical Medicine 2022; 11(6): 1641 doi: 10.3390/jcm11061641
57
Gianluca Esposito, Maria Cazzato, Maria Rinzivillo, Emanuela Pilozzi, Edith Lahner, Bruno Annibale, Francesco Panzuto. Management of type-I gastric neuroendocrine neoplasms: A 10-years prospective single centre studyDigestive and Liver Disease 2022; 54(7): 890 doi: 10.1016/j.dld.2021.11.012
58
O Kurtulan, N Turhan, G Gedikoğlu, A Akyol, C Sökmensüer. Defining prognostic parameters of well-differentiated gastric neuroendocrine tumors based on metastatic potential: a two-center experienceActa Gastro Enterologica Belgica 2022; 85(2): 339 doi: 10.51821/85.2.8601
59
Davide Campana, Nico Pagano, Nicole Brighi, Dario Fabbri, Maria Rinzivillo, Gianfranco Delle Fave, Guido Biasco, Francesco Panzuto. Neuroendocrine Tumors in Real Life2018; : 219 doi: 10.1007/978-3-319-59024-0_16
60
Michael Rassner, Harald Lahner, Nikolas von Bubnoff, Frank Lammert. Geriatrische Onkologie2017; : 1 doi: 10.1007/978-3-662-49083-9_30-1
61
Simona Grozinsky-Glasberg, Krystallenia I. Alexandraki, Anna Angelousi, Eleftherios Chatzellis, Stavros Sougioultzis, Gregory Kaltsas. Gastric CarcinoidsEndocrinology and Metabolism Clinics of North America 2018; 47(3): 645 doi: 10.1016/j.ecl.2018.04.013
62
Francesco Panzuto, Ludovica Magi, Gianluca Esposito, Maria Rinzivillo, Bruno Annibale, Fabiana Zingone. Comparison of Endoscopic Techniques in the Management of Type I Gastric Neuroendocrine Neoplasia: A Systematic ReviewGastroenterology Research and Practice 2021; 2021: 1 doi: 10.1155/2021/6679397
63
Safak Gül-Klein, Alexander Arnold, Christian Oberender, Matylda Zofia Kuzinska, Miguel Enrique Alberto Vilchez, Martina T. Mogl, Beate Rau. Appendixneoplasiencoloproctology 2023; 45(2): 139 doi: 10.1007/s00053-023-00686-5
64
Xiaoxiao Jiao, Zhaodi Wang, Xiaoqian Peng, Lianfeng Zhang, Lin Zhou. Effects of tumor types on treatment strategy formulation and prognostic evaluation of gastric neuroendocrine tumorsFuture Oncology 2020; 16(28): 2197 doi: 10.2217/fon-2020-0150